M Rota1, F Rumi1, V Bagnardi2,3, L Dal Maso4, A Zucchetto4, F Levi5, C La Vecchia6, A Tavani1. 1. Department of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. 2. Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy. 3. Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. 4. Unit of Epidemiology and Biostatistics, CRO Aviano National Cancer Institute, IRCCS, Aviano, Italy. 5. Institute for Social and Preventive Medicine, University of Lausanne, Lausanne, Switzerland. 6. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Abstract
OBJECTIVE: To quantify the relation between body mass index (BMI) and endometrial cancer risk, and to describe the shape of such a relation. DESIGN: Pooled analysis of three hospital-based case-control studies. SETTING: Italy and Switzerland. POPULATION: A total of 1449 women with endometrial cancer and 3811 controls. METHODS: Multivariate odds ratios (OR) and 95% confidence intervals (95% CI) were obtained from logistic regression models. The shape of the relation was determined using a class of flexible regression models. MAIN OUTCOME MEASURE: The relation of BMI with endometrial cancer. RESULTS: Compared with women with BMI 18.5 to <25 kg/m(2) , the odds ratio was 5.73 (95% CI 4.28-7.68) for women with a BMI ≥35 kg/m(2) . The odds ratios were 1.10 (95% CI 1.09-1.12) and 1.63 (95% CI 1.52-1.75) respectively for an increment of BMI of 1 and 5 units. The relation was stronger in never-users of oral contraceptives (OR 3.35, 95% CI 2.78-4.03, for BMI ≥30 versus <25 kg/m(2) ) than in users (OR 1.22, 95% CI 0.56-2.67), and in women with diabetes (OR 8.10, 95% CI 4.10-16.01, for BMI ≥30 versus <25 kg/m(2) ) than in those without diabetes (OR 2.95, 95% CI 2.44-3.56). The relation was best fitted by a cubic model, although after the exclusion of the 5% upper and lower tails, it was best fitted by a linear model. CONCLUSIONS: The results of this study confirm a role of elevated BMI in the aetiology of endometrial cancer and suggest that the risk in obese women increases in a cubic nonlinear fashion. The relation was stronger in never-users of oral contraceptives and in women with diabetes.
OBJECTIVE: To quantify the relation between body mass index (BMI) and endometrial cancer risk, and to describe the shape of such a relation. DESIGN: Pooled analysis of three hospital-based case-control studies. SETTING: Italy and Switzerland. POPULATION: A total of 1449 women with endometrial cancer and 3811 controls. METHODS: Multivariate odds ratios (OR) and 95% confidence intervals (95% CI) were obtained from logistic regression models. The shape of the relation was determined using a class of flexible regression models. MAIN OUTCOME MEASURE: The relation of BMI with endometrial cancer. RESULTS: Compared with women with BMI 18.5 to <25 kg/m(2) , the odds ratio was 5.73 (95% CI 4.28-7.68) for women with a BMI ≥35 kg/m(2) . The odds ratios were 1.10 (95% CI 1.09-1.12) and 1.63 (95% CI 1.52-1.75) respectively for an increment of BMI of 1 and 5 units. The relation was stronger in never-users of oral contraceptives (OR 3.35, 95% CI 2.78-4.03, for BMI ≥30 versus <25 kg/m(2) ) than in users (OR 1.22, 95% CI 0.56-2.67), and in women with diabetes (OR 8.10, 95% CI 4.10-16.01, for BMI ≥30 versus <25 kg/m(2) ) than in those without diabetes (OR 2.95, 95% CI 2.44-3.56). The relation was best fitted by a cubic model, although after the exclusion of the 5% upper and lower tails, it was best fitted by a linear model. CONCLUSIONS: The results of this study confirm a role of elevated BMI in the aetiology of endometrial cancer and suggest that the risk in obesewomen increases in a cubic nonlinear fashion. The relation was stronger in never-users of oral contraceptives and in women with diabetes.
Authors: J-P Obeid; R Stoyanova; D Kwon; M Patel; K Padgett; J Slingerland; C Takita; N Alperin; M Yepes; Y H Zeidan Journal: Clin Transl Oncol Date: 2016-06-30 Impact factor: 3.405
Authors: Pamela L Horn-Ross; Alison J Canchola; Leslie Bernstein; Dennis Deapen; James V Lacey; Eunjung Lee; David O Nelson; Peggy Reynolds Journal: Cancer Causes Control Date: 2016-11-01 Impact factor: 2.532
Authors: Kai Wang; Xinguang Chen; Travis A Gerke; Victoria Y Bird; Hans K Ghayee; Mattia Prosperi Journal: Cancer Med Date: 2018-09-11 Impact factor: 4.452
Authors: Li-Ling Lin; Edward R Kost; Chun-Lin Lin; Philip Valente; Chiou-Miin Wang; Mikhail G Kolonin; Alexes C Daquinag; Xi Tan; Nicholas Lucio; Chia-Nung Hung; Chen-Pin Wang; Nameer B Kirma; Tim H-M Huang Journal: Cell Rep Date: 2020-10-13 Impact factor: 9.423